China National Accord Medicines Corporation Ltd. (SHE:000028)
China · Delayed Price · Currency is CNY 20.22
+0.04 (0.20%)
Jul 10, 2026, 3:04 PM CST
SHE:000028 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHE:000028 stock has a consensus rating of "Hold" and an average price target of ¥24.39. The average 1-year stock price forecast is 20.62% higher than the current stock price, while the lowest is ¥16.53 (-18.25%) and the highest is ¥33.03 (+63.35%).
Price Target: ¥24.39 (+20.62%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SHE:000028 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
75.35B
from 73.42B
Increased by 2.64%
Revenue Next Year
79.37B
from 75.35B
Increased by 5.33%
EPS This Year
2.35
from 1.79
Increased by 31.11%
EPS Next Year
2.55
from 2.35
Increased by 8.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 77.2B | ||
| Avg | 75.4B | ||
| Low | 73.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.2% | ||
| Avg | 2.6% | ||
| Low | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.35 | ||
| Avg | 2.35 | ||
| Low | 2.35 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 31.1% | ||
| Avg | 31.1% | ||
| Low | 31.1% |